Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
37.58B | 35.48B | 32.77B | 16.81B | 13.59B | Gross Profit |
4.83B | 7.43B | 4.62B | -3.00M | -2.98B | EBIT |
1.54B | 2.46B | 1.23B | -2.32B | -7.09B | EBITDA |
4.66B | 5.30B | 3.73B | 92.00M | -3.66B | Net Income Common Stockholders |
1.38B | 1.67B | 791.00M | -2.19B | -6.77B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
8.49B | 8.27B | 8.30B | 7.60B | 5.38B | Total Assets |
47.05B | 45.32B | 43.34B | 42.54B | 39.48B | Total Debt |
14.23B | 13.95B | 15.17B | 16.69B | 15.38B | Net Debt |
12.44B | 12.36B | 13.38B | 14.45B | 13.66B | Total Liabilities |
35.46B | 35.61B | 34.86B | 38.05B | 38.10B | Stockholders Equity |
11.54B | 9.66B | 8.40B | 4.45B | 1.35B |
Cash Flow | Free Cash Flow | |||
-6.00M | 895.00M | 2.66B | -700.00M | -3.58B | Operating Cash Flow |
3.89B | 4.95B | 5.17B | 618.00M | -2.33B | Investing Cash Flow |
-2.33B | -2.98B | -3.44B | -3.02B | -2.34B | Financing Cash Flow |
-1.45B | -2.07B | -2.27B | 2.87B | 5.08B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $29.26B | 8.07 | 27.52% | 1.21% | 4.91% | -27.21% | |
76 Outperform | $24.01B | 6.70 | 33.57% | ― | 5.31% | 35.95% | |
74 Outperform | $8.80B | 6.58 | 12.68% | 3.09% | 6.06% | -11.01% | |
74 Outperform | $26.51B | 15.34 | 21.21% | 1.65% | 5.39% | -15.92% | |
64 Neutral | $4.24B | 11.64 | 5.23% | 249.83% | 4.07% | -10.54% | |
59 Neutral | $17.00B | 35.72 | 5.63% | 2.38% | 3.26% | 27.77% | |
58 Neutral | $6.88B | 12.04 | -21.27% | ― | 1.92% | 36.07% |